S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.05%) $0.927
USD/NOK
(0.04%) $10.85
USD/GBP
(0.02%) $0.792
USD/RUB
(-0.24%) $92.36

Realtime updates for Erytech Pharma S.A. [ERYP]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Jun 2023 @ 15:48

1.30% $ 0.780

Live Chart Being Loaded With Signals

Commentary (28 Jun 2023 @ 15:48):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States...

Stats
Today's Volume 3 205.00
Average Volume 148 586
Market Cap 47.38M
EPS $0 ( 2023-04-26 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -78.00
ATR14 $0.108 (13.85%)

Volume Correlation

Long: 0.13 (neutral)
Short: -0.16 (neutral)
Signal:(42.503) Neutral

Erytech Pharma S.A. Correlation

10 Most Positive Correlations
DGHI0.897
ITMR0.884
AVEO0.874
SOHON0.868
CHDN0.859
DVCR0.851
SOHOB0.848
XLO0.847
BTBT0.846
KIN0.846
10 Most Negative Correlations
AMRB-0.873
SABS-0.861
ORRF-0.857
VTIP-0.857
TRIB-0.846
POLA-0.837
SGMA-0.833
SOPA-0.816
MMAC-0.814
LFMD-0.809

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Erytech Pharma S.A. Correlation - Currency/Commodity

The country flag 0.04
( neutral )
The country flag 0.12
( neutral )
The country flag 0.00
( neutral )
The country flag 0.09
( neutral )
The country flag -0.44
( neutral )
The country flag 0.08
( neutral )

Erytech Pharma S.A. Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.00740
Q4 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0.190
Q3 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.170
Q2 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0.350

Financial Reports:

No articles found.

Erytech Pharma S.A.

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators